p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas

Journal of Oral Pathology & Medicine

Volumn 24, Issue 1, 1995, Pages 18-22

  Regezi, J A ^a   Zarbo, R J ^b   Regev, E ^c   Pisanty, S ^c   Silverman, S ^a   Gazit, D ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

cell proliferation; dysplasia; immunohistochemistry; in situ carcinoma; oral cancer; p53

Indexed keywords

EID: 0029106983     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1995.tb01124.x     Document Type: Article

References (30)

1. WAFI, a potential mediator of p53 tumor suppression
2. The p53 protein is an unusually shaped tetramer that binds directly to DNA
3. The 1993 Walter Hubert Lecture: The role of the p53 tumour‐suppressor gene in tumorigenesis
4. p53 mutations in human bladder cancer: genotypic versus phenotypic patterns
5. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer
6. The p53 tumor suppressor gene
7. p53: the ultimate tumor suppressor gene
8. p53 in tumor pathology: can we trust immunohistochemistry? ‐ revisited
9. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer
10. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis
11. The transcriptional function of wild‐type p53 is inhibited by SV40 large T‐antigen and by HPV‐16 E6 oncoprotein
12. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53–mediated transactivation
13. p53 function and dysfunction
14. Pancreatic adenocarcinomas frequently show p53 gene mutations
15. The correlation of p53 protein expression with proliferative activity and occult metastases in clinical stage 1 non‐seminomatous germ cell tumors of the testis
16. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa
17. Immunohistochemical study of p53 in human lung carcinomas
18. Markers for dysplasia of the upper aerodigestive tract
19. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri
20. Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study
21. Widespread p53 expression in human malignant tumors
22. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions
23. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin
24. Expression of p53 in premalignant and malignant squamous epithelium
25. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas
26. Mutant p53 protein is expressed in Bowen's disease
27. Isolation of human p53‐specific monoclonal antibodies and their use in the studies of human skin
28. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies
29. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma
30. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas